SunnyPharma

Site under development. We’re refining SunnyPharma to bring you a clearer, more helpful experience — thank you for your patience and support as we make things better.

Dr. Jeppe Skov

“`html
MD · Endocrinology
Medical Reviewer · Endocrinology & Metabolic Medicine

Dr. Jeppe Skov

Physician · Endocrinology Specialist · GLP-1 Research Focus

Academic and clinical focus in endocrinology, GLP-1-based therapy, metabolic medicine, weight management, diabetes, and kidney-function considerations.

MD
Physician
PhD
GLP-1 Research
ENDO
Specialty
AU
Aarhus University

Endocrinology Specialist With Academic Focus on GLP-1 and Metabolic Medicine

Dr. Jeppe Skov is a Danish physician and endocrinology specialist. His academic and clinical work centers on metabolic medicine, GLP-1-based therapy, obesity medicine, type 2 diabetes, hormonal regulation of metabolism, and kidney-function considerations relevant to incretin-based treatment.

Dr. Skov studied medicine at Aarhus University and completed doctoral research focused on GLP-1 treatment and kidney function. His academic background is relevant to patient-facing medical content involving GLP-1 receptor agonists, metabolic health, weight management, diabetes overlap, and renal physiology.

For SunnyPharma®, Dr. Skov is listed as a Medical Reviewer for endocrinology and metabolic-medicine content. His reviewer profile is presented to help readers understand the clinical and academic background behind medical review of weight-management and GLP-1-related health education.

Education and Specialist Training

  • 🎓
    Medicine — Aarhus University
    Medical education completed at Aarhus University.
    Medical Education
  • 🎓
    PhD Research — GLP-1 Treatment and Kidney Function
    Doctoral work focused on the effect of GLP-1 treatment on kidney function.
    Doctoral Research
  • 🎓
    Specialist Training — Endocrinology
    Specialist background in diabetes, hormone medicine, metabolic disease, and endocrinology.
    Specialist Training

Academic Focus

Dr. Skov’s academic focus includes GLP-1 pharmacology, incretin-based therapy, kidney-function effects of metabolic treatment, obesity medicine, type 2 diabetes, and the endocrine mechanisms involved in weight regulation and cardiometabolic risk.

  • 📄
    GLP-1-Based Therapy
    Academic and clinical work related to glucagon-like peptide-1 treatment and metabolic outcomes.
    Research Area
  • 📄
    Kidney Function and Metabolic Treatment
    Doctoral focus on the relationship between GLP-1 treatment and renal physiology.
    Research Area
  • 📄
    Obesity, Diabetes, and Metabolic Health
    Clinical endocrinology focus relevant to obesity-related comorbidity, diabetes overlap, and long-term metabolic risk.
    Clinical Focus
SunnyPharma® © 2026 SunnyPharma®. Health education content is medically reviewed prior to publication.
“`
Scroll to Top